查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1657989

印度的體外受精設備市場評估:各產品類型，各次序類型，各終端用戶，各地區，機會及預測，2018～2032年

India In-Vitro Fertilization Instruments Market Assessment, By Product Type, By Procedure Type, By End-user, By Region, Opportunities and Forecast, FY2018-FY2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 120 Pages | 商品交期: 3-5個工作天內

價格

印度 IVF 設備市場預計將從 2024 財年的 11.3 億美元增長到 2032 財年的 20.5 億美元，在預測期內（2025 財年 - 2032 財年）的複合年增長率為 7.70%。

由於 IVF 技術的近期進步和對高效解決方案的需求不斷增加，印度的 IVF 設備市場取得了顯著增長。推動該國市場擴張的主要因素之一是久坐的生活方式和不斷變化的環境條件導致很大一部分人口的生殖功能下降。隨著意識在全國範圍內傳播，圍繞生殖醫學的禁忌正在慢慢解除，人們可以更自由地利用這些醫療選擇。此外，政府對醫療保健基礎設施的投資、技術進步以及對尖端解決方案的不斷增長的需求正在加強市場的成長軌跡。醫療保健領域的快速發展，尤其是亞太地區的快速發展，提供了良好的前景。例如，位於喀拉拉邦的 IVF 醫院薩賓醫院 (Sabine Hospitals) 於 2024 年 2 月宣布，將安裝一台最先進的機器，用於在胎兒還在子宮內時識別遺傳疾病。該機器被稱為下一代定序儀（NGS），用於檢測發育中的胎兒的遺傳疾病。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 印度的體外受精設備市場預測，2018年～2032年

  • 市場規模的分析與預測
    • 各金額
  • 市場佔有率分析與預測
    • 各產品類型
      • 設備
      • 試劑和培養基
      • 軟體和服務
    • 各次序類型
      • 新鮮捐贈者的體外受精
      • 新鮮的非捐贈者體外受精
      • 凍結捐贈者體外受精
      • 凍結非捐贈者體外受精
      • 自然地週期體外受精
      • 其他
    • 各終端用戶
      • 不孕治療診所
      • 醫院
      • 調查機關及學術中心
      • 冷凍銀行
    • 各地區
      • 北部
      • 南部
      • 東部
      • 西部和中部
    • 市場佔有率分析(前五名公司以及其他- 各金額，2024年)，各企業
  • 市場地圖分析，2024年
    • 各產品類型
    • 各次序類型
    • 各終端用戶
    • 各地區

所有市場區隔均提供所有對象地區和國家。

第5章 需求供給分析

第6章 進口和出口的分析

第7章 價值鏈分析

第8章 波特的五力分析

第9章 大環境分析

第10章 價格分析

第11章 市場動態

  • 推動市場要素
  • 市場課題

第12章 市場趨勢與發展

第13章 法規結構和革新

  • 臨床試驗
  • 法規當局的認證

第14章 專利的形勢

第15章 案例研究

第16章 競爭情形

  • 前五名市場領導公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大市場主要企業的形勢
    • CK Birla Healthcare Pvt. Ltd.
      • 公司概要
      • 主要經營團隊
      • 產品和服務
      • 財務狀況(如報告)
      • 主要市場焦點和地理存在感
      • 最近的趨勢/合作/夥伴關係/合併和收購
    • STECH IVF Solutions Private Limited
    • ShineLife Meditec LLP
    • Shivani Scientific Industries(P)Ltd.
    • Navdurga Scientific Pvt. Ltd.
    • Vardhman Medicare Pvt. Ltd.
    • SAR Healthline Private Limited
    • Amensco Medical Technologies Pvt. Ltd.
    • Esco Lifesciences Group
    • IMV Technologies Group(Cryo Bio System)

上述公司不依市場佔有率排序，並且可能會根據研究工作期間獲得的資訊進行更改。

第17章 策略性建議

第18章 關於調查公司·免責聲明

Product Code: MX12771

India in-vitro fertilization instruments market is projected to witness a CAGR of 7.70% during the forecast period FY2025-FY2032F, growing from USD 1.13 billion in FY2024 to USD 2.05 billion in FY2032.

The in-vitro fertilization instruments market in India has grown significantly because of recent advancements in IVF techniques and the growing demand for efficient solutions. One of the primary factors propelling market expansions in the country is most of the population's declining reproductive health due to sedentary lifestyles and shifting environmental conditions. The taboo still associated with it is gradually dissolving and people are more freely availing these medical options as awareness spreads countrywide. Furthermore, government investments in healthcare infrastructure, technological advancements, and the growing demand for cutting-edge solutions reinforce the market's growth trajectory. Rapid advancements in healthcare, particularly in Asia-Pacific, present lucrative prospects. For example, the Sabine Hospital, an IVF hospital based in Kerala, announced in February 2024 that it was all set to install its new and advanced machine to identify genetic diseases while the fetus was still in the womb. This machine, known as the Next Generation Sequencer (NGS), is used to detect genetic diseases in the developing fetus.

Rising Acceptance and Awareness about In-Vitro Fertilization (IVF) Boosts Market Growth

The expansion of India's fertility business has been greatly aided by the increasing awareness and public acceptance of in-vitro fertilization (IVF). Infertility was once a taboo topic, but because of healthcare initiatives, media influence, and education, there is now more openness and acceptance of IVF procedures.

Due to better access to information through digital platforms and healthcare campaigns, couples who have trouble conceiving are now more likely to look for medical options. Furthermore, IVF is now more widely available due to the growth of fertility clinics in Tier 2 and Tier 3 cities, affordable treatment choices, and government initiatives. The industry has grown on the backdrop of shifting attitudes, the acceptance of IVF among LGBTQ+ people and single parents, and corporate insurance coverage for fertility treatments.

For instance, Nova IVF introduced "Fertility Tales," a podcast project in November 2023, to raise awareness about fertility treatment through engaging narratives. The podcast interviews industry stakeholders and shares real patient stories about firsthand experiences with IVF treatment.

Rising Infertility Rate Accelerates India In-Vitro Fertilization (IVF) Instruments Market Growth

The need for in-vitro fertilization (IVF) is being greatly increased by the steep increase in infertility rates in India. The main causes of infertility in both men and women are changing lifestyles, stress, late marriages, obesity, pollution, and rising health disorders such as diabetes and PCOS. Infertility problems affect approximately 10-15% of Indian couples, with a higher prevalence in metropolitan areas, according to the Indian Society of Assisted Reproduction (ISAR).

The spike in infertility cases has spurred the growth of IVF clinics and fertility centres across India. Couples are now more inclined to pursue IVF treatments due to rising awareness, affordability, and technological advancements including AI-driven embryo selection and enhanced cryopreservation techniques. Fertility treatments are also becoming more widely available in India due to initiatives taken by our government and the country's expanding medical tourism.

As infertility cases continue to rise, the Indian IVF market is expected to witness exponential growth in the coming years. For instance, the government of Goa launched the Intrauterine Insemination /In Vitro Fertilization and Assisted Reproductive Technology Centre in August 2023 at the Goa Medical College and Hospital (GMC); providing infertility treatment free of cost.

Rising Infrastructure Fuels the India In-Vitro Fertilization (IVF) Instruments Market Growth

India's in-vitro fertilization (IVF) market has grown tremendously because of the nation's rapidly developing healthcare infrastructure. Fertility treatments are now more widely accessible due to the construction of specialized fertility centers, cutting-edge reproductive laboratories, and enhanced hospital facilities throughout metropolitan and semi-urban areas. Prominent healthcare organizations such as Apollo, Fortis, and Nova IVF Fertility have extended their IVF offerings by incorporating state-of-the-art technology such as genetic testing, sophisticated cryopreservation, and AI-based embryo selection. Infrastructure development is accelerated by government efforts such as Public-Private Partnerships (PPP) and greater foreign investments. Furthermore, the growth of medical tourism has drawn people from all over the world due to India's high-quality fertility therapies and affordability. IVF adoption is also fueled by improved healthcare accessibility and connection in tier-2 and tier-3 cities. With continuous investments in healthcare infrastructure and innovation, India's IVF market is set for exponential growth, catering to rising infertility rates and evolving patient needs.

For instance, in January 2024, CK Birla Healthcare Pvt. Ltd. introduced a new fertility clinic in Meerut, Uttar Pradesh that caters to various fertility issues in people.

Future Market Scenario (FY2025 - FY2032F)

Many factors contribute to the growth of India In-vitro fertilization instruments market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing fertility concerns the population faces today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial.

For instance, in December 2023, Little Angel IVF launched in vitro fertilization treatments such as personalized fertility consultation, comprehensive diagnostic services, advanced IVF treatments, and intracytoplasmic sperm injection (ICSI) for Non-Resident Indian patients.

Key Players Landscape and Outlook

Key players in India's in-vitro fertilization industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, in December 2023, Progenesis IVF Private Limited, a renowned genetic testing brand, expanded its operations to India by launching its first genetic laboratory in New Delhi.

In March 2023, Santaan Fertility Center & Research Institute Private Limited launched a new fertility clinic and research institute in the state of Odisha, India and Indira IVF opened its 116th IVF center in Pune, Maharashtra, an addition to the existing center in Pune.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India In-Vitro Fertilization Instruments Market Outlook, FY2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Equipment
        • 4.2.1.1.1. Incubators
        • 4.2.1.1.2. Cryosystem
        • 4.2.1.1.3. Imaging Systems
        • 4.2.1.1.4. Ovum Aspiration Pumps
        • 4.2.1.1.5. Micromanipulators
        • 4.2.1.1.6. Sperm Separation Systems
        • 4.2.1.1.7. Others
      • 4.2.1.2. Reagents and Media
        • 4.2.1.2.1. Embryo Culture Media
        • 4.2.1.2.2. Cryopreservation Media
        • 4.2.1.2.3. Sperm Processing Media
        • 4.2.1.2.4. Others
      • 4.2.1.3. Software and Services
    • 4.2.2. By Procedure Type
      • 4.2.2.1. Fresh Donor IVF
      • 4.2.2.2. Fresh Non-Donor IVF
      • 4.2.2.3. Frozen Donor IVF
      • 4.2.2.4. Frozen Non-Donor IVF
      • 4.2.2.5. Natural Cycle IVF
      • 4.2.2.6. Others
    • 4.2.3. By End-user
      • 4.2.3.1. Fertility Clinics
      • 4.2.3.2. Hospitals
      • 4.2.3.3. Research Institutes and Academic Centers
      • 4.2.3.4. Cryobanks
    • 4.2.4. By Region
      • 4.2.4.1. North
      • 4.2.4.2. South
      • 4.2.4.3. East
      • 4.2.4.4. West & Central
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
  • 4.3. Market Map Analysis, FY2024
    • 4.3.1. By Product Type
    • 4.3.2. By Procedure Type
    • 4.3.3. By End-user
    • 4.3.4. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

  • 13.1. Clinical Trials
  • 13.2. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players
    • 16.3.1. CK Birla Healthcare Pvt. Ltd.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 16.3.2. STECH IVF Solutions Private Limited
    • 16.3.3. ShineLife Meditec LLP
    • 16.3.4. Shivani Scientific Industries (P) Ltd.
    • 16.3.5. Navdurga Scientific Pvt. Ltd.
    • 16.3.6. Vardhman Medicare Pvt. Ltd.
    • 16.3.7. SAR Healthline Private Limited
    • 16.3.8. Amensco Medical Technologies Pvt. Ltd.
    • 16.3.9. Esco Lifesciences Group
    • 16.3.10. IMV Technologies Group (Cryo Bio System)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. India In-Vitro Fertilization Market, By Value, In USD Billion, FY2018-FY2032F
  • Figure 2. India In-Vitro Fertilization Market Share (%), By Product Type, FY2018-FY2032F
  • Figure 3. India In-Vitro Fertilization Market Share (%), By Procedure Type, FY2018-FY2032F
  • Figure 4. India In-Vitro Fertilization Market Share (%), By End-user, FY2018-FY2032F
  • Figure 5. India In-Vitro Fertilization Market Share (%), By Region, FY2018-FY2032F
  • Figure 6. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
  • Figure 7. By Procedure Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
  • Figure 8. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2024
  • Figure 9. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2024